← Open Payments lookup

JENNIFER CLARK: Open Payments

NPI 1649993320 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,122 in 60 payments from 18 companies in 2025. Trend: 2023 $1,093 · 2024 $1,367 · 2025 $1,122

Food & beverage: $1,122
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$222
Amgen Inc.12$158
PFIZER INC.6$136
ABBVIE INC.6$111
Boehringer Ingelheim Pharmaceuticals, Inc.4$80
Otsuka America Pharmaceutical, Inc.3$78
Axsome Therapeutics, Inc.2$49
Bayer Healthcare Pharmaceuticals Inc.3$42
Novartis Pharmaceuticals Corporation2$42
Astellas Pharma US Inc2$31

Products named: OTEZLA, AIRSUPRA, FARXIGA, REXULTI, LINZESS, JARDIANCE, ELIQUIS, PREVNAR 20.

Industry payments across TX — which companies pay providers there.